We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Gates Foundation Challenges World's Scientists

By Biotechdaily staff writers
Posted on 12 Feb 2003
The Bill and Melinda Gates Foundation has announced a research program for improving the health of people in developing countries. More...
The first phase will seek to identify the leading causes of death in poorer countries, to be followed by an international US$200 million competition designed to entice scientists to find ways to prevent those causes of death. The program was announced at the meeting of the World Economic Forum in Davos (Switzerland) by Mr. Gates, who is the founder of Microsoft. He emphasized that health problems are preventing economic growth in poorer countries.

Around four billion people live in developing countries, representing two-thirds of the world's population, yet only 10% of all medical research is dedicated to diseases such as malaria, tuberculosis, malnutrition and other conditions causing 90% of worldwide health problems. Instead, most researchers are focusing on "rich world” diseases, according to Mr. Gates.

An international panel of scientists will decide on specific challenges in global health that would lead to improved well being and fewer deaths. Dr. Harold Varmus, president of Memorial Sloan-Kettering Cancer Center (New York, NY) and formerly a director of the US National Institutes of Health, has been appointed chairman of the panel. During the summer of 2003, the panel will publish a list of priorities. Among the challenges being considered are: finding new approaches to protect children from diarrhea and respiratory infections, finding new approaches to prevent and treat patients with AIDS, and finding a way to block the reactivation of tuberculosis.

Following this phase, grants of up to US$20 million each will be awarded over the next three to five years. These will probably be awarded to coalitions of scientists from different institutions and disciplines and also to some individual scientists. The grants are to be administered by the Foundation for the National Institutes of Health (Bethesda, MD, USA). Mr. Gates said the program was inspired by a German mathematician, David Hilbert, who challenged other mathematicians in 1900 to solve 23 problems. This resulted in mathematic breakthroughs and other advances, including the development of computers.





Related Links:
Memorial Sloan-Kettering
Foundation for the National Institutes of Health

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.